News and culture through the lens of Southern California.
Hosted by A Martínez
Airs Weekdays 2 to 3 p.m.

Amid growing opioid risk, pharma makes push to market OxyContin abroad




With concern growing about the opioid addiction epidemic in the US, companies are pushing to market overseas, find a new L.A. Times investigation into OxyContin.
With concern growing about the opioid addiction epidemic in the US, companies are pushing to market overseas, find a new L.A. Times investigation into OxyContin.
Hero Images/Getty Images

Listen to story

08:03
Download this story 19MB

It's probably the most notorious prescription drug of our times – OxyContin.

Here in the US, because of widespread abuse and addiction, authorities are clamping down on it, and other opium-based painkillers. So the companies that make opioid drugs are looking overseas boost sales, and that's causing concern among medical officials.

The international push is coming from a group of companies, known as Mundipharma.

Los Angeles Times journalist Harriet Ryan spoke with A Martinez about her reporting.

READ: OxyContin goes global — “We’re only just getting started” in the L.A. Times

To listen to the full interview, click on the blue media player above.